Osteoporose Nieuws
Wekelijks verschijnen er nieuwe onderzoek, publicaties en artikelen over osteoporose. Een selectie uit dit aanbod wordt doorgeplaatst op deze website. Klik hier voor de rss-nieuwsfeeds.
-
Incidence of distal radius fracture in a general population in southern Sweden in 2016 compared with 2001.
Osteoporos Int. 2020 Jan 13;: Authors: Ali M, Eiriksdottir A, Murtadha M, Åkesson A, Atroshi I INTRODUCTION: We conducted an epidemiological study on residents of northeastern Skåne in southern Sweden... Lees meer
Gepost op 16 januari 2020
-
Adherence to fracture liaison service programs in patients over 70: the hidden part of the iceberg.
Osteoporos Int. 2020 Jan 11;: Authors: Mugnier B, Daumas A, Doddoli S, Belmeliani S, Couderc AL, Mizzi B, Lévêque P, Villani P INTRODUCTION: FLS programs are considered the most effective interventions for... Lees meer
Gepost op 16 januari 2020
-
Correlates of T50 and relationships with bone mineral density in community-living older men: the osteoporotic fractures in men (MrOS) study.
Osteoporos Int. 2019 Jul;30(7):1529-1531 Authors: Bullen AL, Anderson CAM, Hooker ER, Kado DM, Orwoll E, Pasch A, Ix JH PURPOSE: T50 is a novel serum-based marker that assesses the propensity of calcification in serum.... Lees meer
Gepost op 16 januari 2020
-
Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies.
PLoS One. 2020;15(1):e0227765 Authors: des Bordes J, Prasad S, Pratt G, Suarez-Almazor ME, Lopez-Olivo MA BACKGROUND: Patients with low bone density or osteoporosis need information for effective prevention or disease... Lees meer
Gepost op 16 januari 2020
-
Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study.
Clin Rheumatol. 2020 Jan 14;: Authors: Yamada Y, Tada M, Mandai K, Hidaka N, Inui K, Nakamura H INTRODUCTION: Patients with rheumatoid arthritis (RA) are at higher risk of sarcopenia because of joint dysfunction and... Lees meer
Gepost op 16 januari 2020
-
Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin.
J Am Heart Assoc. 2020 Jan 21;9(2):e013845 Authors: Huang HK, Liu PP, Hsu JY, Lin SM, Peng CC, Wang JH, Yeh JI, Loh CH Background Warfarin, a vitamin K antagonist, has been shown to affect bone mineral density and cause... Lees meer
Gepost op 12 januari 2020
-
MRI-based assessment of proximal femur strength compared to mechanical testing.
Bone. 2020 Jan 08;:115227 Authors: Rajapakse CS, Farid AR, Kargilis DC, Jones BC, Lee JS, Johncola AJ, Batzdorf AS, Shetye SS, Hast MW, Chang G Half of the women who sustain a hip fracture would not qualify for... Lees meer
Gepost op 12 januari 2020
-
Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA-3 TriaL (VITAL).
J Bone Miner Res. 2020 Jan 10;: Authors: LeBoff MS, Chou SH, Murata EM, Donlon CM, Cook NR, Mora S, Lee IM, Kotler G, Bubes V, Buring JE, Manson JE Although supplemental vitamin D is used to promote bone health in the... Lees meer
Gepost op 12 januari 2020
-
Reassessment Intervals for Transition From Low to High Fracture Risk Among Adults Older Than 50 Years.
JAMA Netw Open. 2020 Jan 03;3(1):e1918954 Authors: Leslie WD, Morin SN, Lix LM, Martineau P, Bryanton M, McCloskey EV, Johansson H, Harvey NC, Kanis JA Importance: Fracture risk scores are used to identify individuals at... Lees meer
Gepost op 12 januari 2020
-
Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients.
Osteoporos Int. 2020 Jan 03;: Authors: McKee H, Ioannidis G, Lau A, Treleaven D, Gangji A, Ribic C, Pack MW, Papaioannou A, Adachi JD A retrospective chart review was conducted on 85 renal transplant patients aged... Lees meer
Gepost op 10 januari 2020
-
Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture risk.
Osteoporos Int. 2020 Jan 03;: Authors: Bouxsein ML, Zysset P, Glüer CC, McClung M, Biver E, Pierroz DD, Ferrari SL, IOF Working Group on Hip Bone Strength as a Therapeutic Target INTRODUCTION: The risk of hip... Lees meer
Gepost op 10 januari 2020
-
History of Previous Fracture and Imminent Fracture Risk in Swedish Women Aged 55-90 Years Presenting with a Fragility Fracture.
J Bone Miner Res. 2020 Jan 08;: Authors: Toth E, Banefelt J, Åkesson K, Spångeus A, Ortsäter G, Libanati C The term "fracture cascade" refers to the sequence of fragility fractures resulting... Lees meer
Gepost op 10 januari 2020
-
History of etidronate.
Bone. 2020 Jan 03;:115222 Authors: Watts NB, Chesnut CH, Genant HK, Harris ST, Jackson RD, Licata AA, Miller PD, Mysiw WJ, Richmond B, Valent D Etidronate is a non-nitrogen-containing bisphosphonate. Because it binds with... Lees meer
Gepost op 10 januari 2020
-
Time to benefit and the long-term persistence of new users of oral bisphosphonates.
J Bone Miner Metab. 2020 Jan 01;: Authors: Friesen KJ, Bugden S, Falk J INTRODUCTION: This study aimed to examine long-term persistence in new users of oral bisphosphonates in a population-wide cohort in Manitoba, Canada.... Lees meer
Gepost op 05 januari 2020
-
Delayed Denosumab Injections and Bone Mineral Density Response: An Electronic Health Record-based Study.
J Clin Endocrinol Metab. 2020 Jan 02;: Authors: Lyu H, Zhao SS, Yoshida K, Tedeschi SK, Xu C, Nigwekar SU, Leder BZ, Solomon DH CONTEXT: Discontinuation of denosumab leads to a rapid reversal of its therapeutic effect.... Lees meer
Gepost op 05 januari 2020
-
Zoledronate Slows Weight Loss and Maintains Fat Mass in Osteopenic Older Women: Secondary Analysis of a Randomized Controlled Trial.
Calcif Tissue Int. 2020 Jan 02;: Authors: Reid IR, Horne AM, Mihov B, Stewart A, Bastin S, Gamble GD Studies in mice have suggested that osteocalcin plays an important role in glucose and fat metabolism. Since... Lees meer
Gepost op 05 januari 2020
-
Risk for Infections During Treatment With Denosumab for Osteoporosis: a Systematic Review and Meta-analysis.
J Clin Endocrinol Metab. 2020 Jan 03;: Authors: Diker-Cohen T, Rosenberg D, Avni T, Shepshelovich D, Tsvetov G, Gafter-Gvili A CONTEXT: Denosumab inhibits the receptor activator of nuclear factor κ-Β ligand, an... Lees meer
Gepost op 05 januari 2020
-
Role of Metformin on Osteoblast Differentiation in Type 2 Diabetes.
Biomed Res Int. 2019;2019:9203934 Authors: Jiating L, Buyun J, Yinchang Z Metformin, an effective hypoglycemic, can modulate different points of malignant mass, polycystic ovary syndrome (PCOS), cardiovascular diseases,... Lees meer
Gepost op 01 januari 2020
-
DRESS syndrome in response to Denosumab: First documented case report.
Bone Rep. 2020 Jun;12:100239 Authors: Al-Attar M, De Santis M, Massarotti M Denosumab is an antiresorptive drug targeting RANK ligand, currently licensed for postmenopausal and male osteoporosis, bone loss associated with... Lees meer
Gepost op 01 januari 2020
-
Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis.
Osteoporos Int. 2019 Dec 20;: Authors: Ko Y, Lee G, Kim B, Park M, Jang Y, Lim W INTRODUCTION: Osteoclasts are responsible for bone resorption in bone-related disorders. Anti-cytokine therapeutic antibodies such as... Lees meer
Gepost op 25 december 2019
-
Changes in vascular calcification and bone mineral density in calcium supplement users from the Canadian Multi-center Osteoporosis Study (CaMOS).
Atherosclerosis. 2019 Dec 16;: Authors: Hulbert M, Turner ME, Hopman WM, Anastassiades T, Adams MA, Holden RM BACKGROUND AND AIMS: Calcium supplements have been associated with increased cardiovascular events. This... Lees meer
Gepost op 25 december 2019
-
Circulating miR-181c-5p and miR-497-5p are potential biomarkers for prognosis and diagnosis of osteoporosis.
J Clin Endocrinol Metab. 2019 Dec 24;: Authors: Ma J, Lin X, Chen C, Li S, Zhang S, Chen Z, Li D, Zhao F, Yang C, Qiu W, Xiao Y, Zhang K, Miao Z, Yang T, Qian A CONTEXT: Osteoporosis is a degenerative bone disease in... Lees meer
Gepost op 25 december 2019
-
Medical management of patients after atypical femur fractures: a systematic review and recommendations from ECTS.
J Clin Endocrinol Metab. 2019 Dec 23;: Authors: van de Laarschot DM, McKenna MJ, Abrahamsen B, Langdahl B, Cohen-Solal M, Guañabens N, Eastell R, Ralston SH, Zillikens MC CONTEXT: Atypical femur fractures (AFFs)... Lees meer
Gepost op 25 december 2019
-
Pharmacogenomics in medication-related osteonecrosis of the jaw: a systematic literature review.
Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10184-10194 Authors: Bastida-Lertxundi N, Leizaola-Cardesa IO, Hernando-Vázquez J, Muguerza-Iraola R, Aguilar-Salvatierra A, Gómez-Moreno G, Crettaz JS OBJECTIVE:... Lees meer
Gepost op 19 december 2019
-
The association between fast increase in bone turnover during the menopause transition and subsequent fracture.
J Clin Endocrinol Metab. 2019 Dec 16;: Authors: Shieh A, Greendale GA, Cauley JA, Karlamangla AS CONTEXT: Bone turnover increases rapidly during the menopause transition (MT), and plateaus above premenopausal levels in... Lees meer
Gepost op 19 december 2019
-
Patient engagement in clinical guidelines development: input from > 1000 members of the Canadian Osteoporosis Patient Network.
Osteoporos Int. 2019 Dec 14;: Authors: Morin SN, Djekic-Ivankovic M, Funnell L, Giangregorio L, Rodrigues IB, Ridout R, Feldman S, Kim S, McDonald-Blumer H, Kline G, Ward WE, Santesso N, Leslie WD INTRODUCTION: Patient... Lees meer
Gepost op 19 december 2019
-
Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.
Osteoporos Int. 2019 Dec 14;: Authors: Merlijn T, Swart KMA, van der Horst HE, Netelenbos JC, Elders PJM This systematic review and meta-analysis showed a significant reduction of (major) osteoporotic fractures and hip... Lees meer
Gepost op 19 december 2019
-
Denosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?
Osteoporos Int. 2019 Dec 14;: Authors: Tsvetov G, Amitai O, Shochat T, Shimon I, Akirov A, Diker-Cohen T PURPOSE: RCTs have reported a 0.05-1.7% rate of hypocalcemia in denosumab-treated postmenopausal women with... Lees meer
Gepost op 19 december 2019
-
Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial.
Osteoporos Int. 2019 Dec 16;: Authors: Lopez-Olivo MA, des Bordes JKA, Lin H, Rizvi T, Volk RJ, Suarez-Almazor ME INTRODUCTION: Innovative approaches to patient education about self-management in osteoporosis may improve... Lees meer
Gepost op 19 december 2019
-
Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical Trials.
JBMR Plus. 2019 Dec;3(12):e10239 Authors: Crandall CJ, Larson J, Cauley JA, Schousboe JT, LaCroix AZ, Robbins JA, Watts NB, Ensrud KE The ability of the fracture risk assessment tool (FRAX) to discriminate between women... Lees meer
Gepost op 19 december 2019
-
Does the Prediction Accuracy of Osteoporotic Fractures by BMD and Clinical Risk Factors Vary With Fracture Site?
JBMR Plus. 2019 Dec;3(12):e10238 Authors: Iconaru L, Moreau M, Kinnard V, Baleanu F, Paesmans M, Karmali R, Body JJ, Bergmann P Several clinical risk factors (CRFs) have been shown to predict the risk of fragility... Lees meer
Gepost op 19 december 2019
-
Rib fractures after blunt thoracic trauma in patients with normal versus diminished bone mineral density: a retrospective cohort study.
Osteoporos Int. 2019 Dec 11;: Authors: Prins JTH, Van Lieshout EMM, Reijnders MRL, Verhofstad MHJ, Wijffels MME This study aimed to evaluate rib fracture rate as well as rib fracture characteristics after thoracic trauma... Lees meer
Gepost op 15 december 2019
-
Education intervention for older adults with osteoporosis: a systematic review.
Osteoporos Int. 2019 Dec 11;: Authors: Gai QY, Lv H, Li YP, Fu QM, Li P BACKGROUND: Various education interventions were developed for preventing or managing OP, but the effects of those interventions on older adults were... Lees meer
Gepost op 15 december 2019
-
Position Statement: Exercise Guidelines to Increase Peak Bone Mass in Adolescents.
J Bone Metab. 2019 Nov;26(4):225-239 Authors: Min SK, Oh T, Kim SH, Cho J, Chung HY, Park DH, Kim CS Background: An increase in bone mineral density during adolescence increases resistance to fractures in older age. The... Lees meer
Gepost op 15 december 2019
-
Perspective on skeletal health in inflammatory bowel disease.
Osteoporos Int. 2019 Dec 10;: Authors: van Bodegraven AA, Bravenboer N Osteopenia and osteoporosis are common features in inflammatory bowel disease (IBD), comprising both Crohn's disease and ulcerative colitis.... Lees meer
Gepost op 13 december 2019
-
Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long-Term Risk for Fragility Fracture: A Prospective Study.
J Bone Miner Res. 2019 Dec 10;: Authors: Chapurlat R, Bui M, Sornay-Rendu E, Zebaze R, Delmas PD, Liew D, Lespessailles E, Seeman E More than 70% of women sustaining fractures have osteopenia or "normal" bone... Lees meer
Gepost op 13 december 2019
-
Differences in geometric strength at the contralateral hip between men with hip fracture and non-fractured comparators.
Bone. 2019 Dec 05;:115187 Authors: Rathbun AM, Magaziner J, Shardell MD, Beck TJ, Yerges-Armstrong LM, Orwig D, Hicks GE, Ryan AS, Hochberg MC Older men sustain excess bone mineral density (BMD) declines after hip... Lees meer
Gepost op 10 december 2019
-
Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates.
Osteoporos Int. 2019 Nov 28;: Authors: Miller PD, Pannacciulli N, Malouf-Sierra J, Singer A, Czerwiński E, Bone HG, Wang C, Huang S, Chines A, Lems W, Brown INTRODUCTION: We conducted a patient-level pooled analysis of... Lees meer
Gepost op 05 december 2019
-
A road map for understanding molecular and genetic determinants of osteoporosis.
Nat Rev Endocrinol. 2019 Dec 02;: Authors: Yang TL, Shen H, Liu A, Dong SS, Zhang L, Deng FY, Zhao Q, Deng HW Osteoporosis is a highly prevalent disorder characterized by low bone mineral density and an increased risk of... Lees meer
Gepost op 05 december 2019
-
The exploration of feature extraction and machine learning for predicting bone density from simple spine X-ray images in a Korean population.
Skeletal Radiol. 2019 Nov 23;: Authors: Lee S, Choe EK, Kang HY, Yoon JW, Kim HS OBJECTIVE: Osteoporosis is hard to detect before it manifests symptoms and complications. In this study, we evaluated machine... Lees meer
Gepost op 27 november 2019
-
Understanding patient experiences and challenges to osteoporosis care delivered virtually by telemedicine: a mixed methods study.
Osteoporos Int. 2019 Nov 23;: Authors: Palcu P, Munce S, Jaglal SB, Allin S, Chishtie JA, Silverstein A, Kim S INTRODUCTION: There is limited research on the role of telemedicine (TM) in the management of osteoporosis... Lees meer
Gepost op 27 november 2019
-
Association between vertebral fractures and coronary artery calcification in current and former smokers in the ECLIPSE cohort.
Osteoporos Int. 2019 Nov 25;: Authors: van Dort MJ, Driessen JHM, Geusens P, Romme EAPM, Smeenk FWJM, Rahel BM, Eisman JA, Wouters EFM, van den Bergh JPW INTRODUCTION: Prevalence of VFs among smokers and patients with... Lees meer
Gepost op 27 november 2019
-
A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
Osteoporos Int. 2019 Nov 25;: Authors: Ohbayashi Y, Iwasaki A, Nakai F, Mashiba T, Miyake M PURPOSE: Teriparatide (TPTD) treatment for Stage II-III medication-related osteonecrosis of the jaw (MRONJ) in osteoporotic... Lees meer
Gepost op 27 november 2019
-
Cost-Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate-Alone Strategies in High-Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide.
JBMR Plus. 2019 Nov;3(11):e10233 Authors: Mori T, Crandall CJ, Ganz DA Teriparatide, currently only available in brand form in the United States, is a costly drug approved for the treatment of postmenopausal osteoporotic... Lees meer
Gepost op 27 november 2019
-
Identifying genetic variants underlying medication-induced osteonecrosis of the jaw in cancer and osteoporosis: a case control study.
J Transl Med. 2019 Nov 20;17(1):381 Authors: Lee KH, Kim SH, Kim CH, Min BJ, Kim GJ, Lim Y, Kim HS, Ahn KM, Kim JH BACKGROUND: Bisphosphonate-induced osteonecrosis of the jaw (BRONJ) presents with a typical pattern of jaw... Lees meer
Gepost op 24 november 2019
-
Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.
Osteoporos Int. 2019 Nov 21;: Authors: Cui L, He T, Jiang Y, Li M, Wang O, Jiajue R, Chi Y, Xu Q, Xing X, Xia W INTRODUCTION: The purpose of this study is to estimate FRAX-based fracture probabilities in Mainland China... Lees meer
Gepost op 24 november 2019
-
Kidney function and its association to imminent, short- and long-term fracture risk-a longitudinal study in older women.
Osteoporos Int. 2019 Nov 21;: Authors: Malmgren L, McGuigan FE, Christensson A, Akesson KE INTRODUCTION: With age, kidney function declines. Though well known that chronic kidney disease is associated with increased... Lees meer
Gepost op 24 november 2019
-
Association between dairy intake and fracture in an Australian-based cohort of women: a prospective study.
BMJ Open. 2019 Nov 21;9(11):e031594 Authors: Aslam H, Holloway-Kew KL, Mohebbi M, Jacka FN, Pasco JA OBJECTIVE: Given the inconsistent evidence on dairy consumption and risk of fracture, we assessed the association... Lees meer
Gepost op 24 november 2019
-
Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.
Osteoporos Int. 2019 Nov 22;: Authors: Morley J, Moayyeri A, Ali L, Taylor A, Feudjo-Tepie M, Hamilton L, Bayly J INTRODUCTION: Persistence with osteoporosis therapies has historically been poor. To treat this chronic and... Lees meer
Gepost op 24 november 2019
-
Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
Osteoporos Int. 2018 Aug;29(8):1737-1745 Authors: Thongprayoon C, Acharya P, Acharya C, Chenbhanich J, Bathini T, Boonpheng B, Sharma K, Wijarnpreecha K, Ungprasert P, Gonzalez Suarez ML, Cheungpasitporn W The incidence... Lees meer
Gepost op 21 november 2019
-
Proton pump inhibitors and fracture risk. The HUNT study, Norway.
Osteoporos Int. 2019 Nov 18;: Authors: Hoff M, Skovlund E, Skurtveit S, Meyer HE, Langhammer A, Søgaard AJ, Syversen U, Forsmo S, Abrahamsen B, Schei B INTRODUCTION: Proton pump inhibitors (PPIs) are widely... Lees meer
Gepost op 21 november 2019
-
The effect of bisphosphosphonates on bone turnover and bone balance in postmenopausal women with osteoporosis: The T-score bone marker approach in the TRIO study.
Bone. 2019 Nov 15;:115158 Authors: Gossiel F, Paggiosi MA, Naylor KE, McCloskey EV, Walsh J, Peel N, Eastell R Postmenopausal osteoporosis is characterised by increased bone turnover and an imbalance between bone... Lees meer
Gepost op 21 november 2019
-
Impact of muscle atrophy on bone metabolism and bone strength: implications for muscle-bone crosstalk with aging and disuse.
Osteoporos Int. 2018 Aug;29(8):1713-1720 Authors: Bettis T, Kim BJ, Hamrick MW Bone fractures in older adults are often preceded by a loss of muscle mass and strength. Likewise, bone loss with prolonged bed rest, spinal... Lees meer
Gepost op 21 november 2019
-
Denosumab failure associated with escape from suppression of bone resorption.
Bone. 2019 Nov 13;:115157 Authors: Jones AR, Sim IW Denosumab leads to sustained suppression of bone turnover if given every 6 months, with escape occurring approximately 2 to 3 months after the last dose. Whilst escape... Lees meer
Gepost op 17 november 2019
-
The Association of Bone Mineral Density with Mortality in a COPD Cohort. The HUNT Study, Norway.
COPD. 2019 Nov 11;:1-9 Authors: Vikjord SAA, Brumpton BM, Mai XM, Bhatta L, Vanfleteren L, Langhammer A In individuals with chronic obstructive pulmonary disease (COPD), the presence of comorbidities is associated with... Lees meer
Gepost op 14 november 2019
-
Diffusion MRI for Assessment of Bone Quality; A Review of Findings in Healthy Aging and Osteoporosis.
J Magn Reson Imaging. 2019 Nov 11;: Authors: Fathi Kazerooni A, Pozo JM, McCloskey EV, Saligheh Rad H, Frangi AF Diffusion MRI (dMRI) is a growing imaging technique with the potential to provide biomarkers of tissue... Lees meer
Gepost op 14 november 2019
-
Fracture incidence after denosumab discontinuation: Real-world data from a large healthcare provider.
Bone. 2019 Nov 09;:115150 Authors: Tripto-Shkolnik L, Fund N, Rouach V, Chodick G, Shalev V, Goldshtein I BACKGROUND: Vertebral fractures (VF) upon Denosumab (DMAB) discontinuation were first described as a distinct... Lees meer
Gepost op 14 november 2019
-
Temporal trends and factors associated with bisphosphonate discontinuation and restart.
J Bone Miner Res. 2019 Nov 12;: Authors: Adami G, Jaleel A, Curtis JR, Delzell E, Chen R, Yun H, Daigle S, Arora T, Danila MI, Wright NC, Cadarette SM, Mudano A, Foster J, Saag KG Adverse events related to long-term use... Lees meer
Gepost op 14 november 2019
-
Physiotherapy rehabilitation for osteoporotic vertebral fracture-a randomised controlled trial and economic evaluation (PROVE trial).
Osteoporos Int. 2019 Nov 12;: Authors: Barker KL, Newman M, Stallard N, Leal J, Lowe CM, Javaid MK, Noufaily A, Hughes T, Smith D, Gandhi V, Cooper C, Lamb SE, PROVE trial group INTRODUCTION: To evaluate the clinical and... Lees meer
Gepost op 14 november 2019
-
Multiple simultaneous fractures are associated with higher all-cause mortality: results from a province-wide fracture liaison service.
Osteoporos Int. 2019 Nov 13;: Authors: Sujic R, Luo J, Beaton DE, Bogoch ER, Sale JEM, Jaglal S, Jain R, Mamdani M, Ontario Osteoporosis Strategy Fracture Screening and Prevention Program Evaluation Team PURPOSE: To... Lees meer
Gepost op 14 november 2019
-
Peripheral quantitative computed tomography (pQCT)-based finite element analysis provides enhanced diagnostic performance in identifying non-vertebral fracture patients compared with dual-energy X-ray absorptiometry.
Osteoporos Int. 2019 Nov 13;: Authors: Jiang H, Robinson DL, Yates CJ, Lee PVS, Wark JD INTRODUCTION: Dual-energy X-ray absorptiometry (DXA), the predominant clinical method for diagnosing osteoporosis, has limitations in... Lees meer
Gepost op 14 november 2019
-
Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.
Osteoporos Int. 2019 Nov 13;: Authors: Kanis JA, Harvey NC, McCloskey E, Bruyère O, Veronese N, Lorentzon M, Cooper C, Rizzoli R, Adib G, Al-Daghri N, Campusano C, Chandran M, Dawson-Hughes B, Javaid K, Jiwa F,... Lees meer
Gepost op 14 november 2019
-
Associations between health-related quality of life, physical function and pain in older women with osteoporosis and vertebral fracture.
BMC Geriatr. 2019 Nov 04;19(1):298 Authors: Stanghelle B, Bentzen H, Giangregorio L, Pripp AH, Bergland A BACKGROUND: Osteoporosis and vertebral fractures represent a major health burden worldwide, and the prevalence of... Lees meer
Gepost op 09 november 2019
-
Back Pain-Inducing Test, a novel and sensitive screening test for painful osteoporotic vertebral fractures: A prospective clinical study.
J Bone Miner Res. 2019 Nov 06;: Authors: Jin H, Ma X, Liu Y, Yin X, Zhu J, Wang Z, Fan W, Jin Y, Pu J, Zhao J, Liu M, Liu P To detect painful vertebral fractures (VFs) in back pain populations at risk of osteoporosis, we... Lees meer
Gepost op 09 november 2019
-
Inequalities in prescription rates of anti-osteoporosis drugs in primary care in England: a practice-level prescribing data analysis in 2013-2018.
Bone. 2019 Nov 02;:115125 Authors: Agirrezabal I, Cabasés JM, Di Tanna GL, Sánchez-Iriso E OBJECTIVE: To investigate potential variations in prescription rates of anti-osteoporosis drugs at the general... Lees meer
Gepost op 09 november 2019
-
The Effect of 1 Year of Romosozumab on the Incidence of Clinical Vertebral Fractures in Postmenopausal Women With Osteoporosis: Results From the FRAME Study.
JBMR Plus. 2019 Oct;3(10):e10211 Authors: Geusens P, Oates M, Miyauchi A, Adachi JD, Lazaretti-Castro M, Ebeling PR, Perez Niño CA, Milmont CE, Grauer A, Libanati C Radiographic vertebral fractures (VFxs) are the... Lees meer
Gepost op 09 november 2019
-
Impact of risk minimisation measures on the use of strontium ranelate in Europe: a multi-national cohort study in 5 EU countries by the EU-ADR Alliance.
Osteoporos Int. 2019 Nov 06;: Authors: Berencsi K, Sami A, Ali MS, Marinier K, Deltour N, Perez-Guthann S, Pedersen L, Rijnbeek P, Van der Lei J, Lapi F, Simonetti M, Reyes C, Sturkenboom MCJM, Prieto-Alhambra D... Lees meer
Gepost op 09 november 2019
-
The Nottingham Spinal Health (NoSH) Study: a cohort study of patients hospitalised with vertebral fragility fractures.
Osteoporos Int. 2019 Nov 06;: Authors: Ong T, Sahota O, Gladman JRF PURPOSE: Patients admitted to hospital with vertebral fragility fractures are elderly and have complex care needs who may benefit from specialist... Lees meer
Gepost op 09 november 2019
-
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis.
Bone. 2019 Oct 30;:115121 Authors: Lv F, Cai X, Yang W, Gao L, Chen L, Wu J, Ji L BACKGROUND: Osteoporosis and cardiovascular (CV) diseases are closely correlated. RANKL/RANK/OPG pathway and Wnt signalling pathway both... Lees meer
Gepost op 07 november 2019
-
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
Lancet Diabetes Endocrinol. 2019 Oct 29;: Authors: McClung MR, O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T,... Lees meer
Gepost op 07 november 2019
-
Declining Trend in Osteoporosis Management and Screening Following Vertebral Compression Fractures - A National Analysis of Commercial Insurance and Medicare Advantage Beneficiaries.
Spine J. 2019 Nov 01;: Authors: Malik AT, Retchin S, Phillips FM, Xu W, Peters K, Yu E, Khan SN BACKGROUND CONTEXT: Despite the increasing national incidence, osteoporosis and its associated co-management, often remain an... Lees meer
Gepost op 07 november 2019
-
Pitfalls in bone density monitoring in prostate cancer during anti-resorptive treatment.
Osteoporos Int. 2018 Jul;29(7):1665-1670 Authors: Cheung YM, Ramchand SK, Grossmann M A 74-year-old man presented to the Andrology Clinic for management of potential complications of androgen deprivation therapy for... Lees meer
Gepost op 03 november 2019
-
Exercise effects on bone mineral density in older men: a systematic review with special emphasis on study interventions.
Osteoporos Int. 2018 Jul;29(7):1493-1504 Authors: Kemmler W, Shojaa M, Kohl M, von Stengel S The primary aim of this systematic review was to determine the effect of exercise on bone mineral density (BMD) in healthy older... Lees meer
Gepost op 03 november 2019
-
Bone mineral density at different sites and 5 years mortality in end-stage renal disease patients: A cohort study.
Bone. 2019 Oct 24;:115075 Authors: Iseri K, Qureshi AR, Dai L, Ripsweden J, Heimbürger O, Barany P, Bergström I, Stenvinkel P, Brismar TB, Lindholm B BACKGROUND: Bone disease with osteoporosis and renal... Lees meer
Gepost op 03 november 2019
-
Proton pump inhibitor use is associated with hip fracture development: a nationwide population-based cohort study.
Korean J Intern Med. 2019 Nov 04;: Authors: Min YW, Lee YC, Kim K, Ryu S, Hong KS, Jeon HH, Kim YS, Park JH, Son HJ, Rhee PL Background/Aims: Effect of proton pump inhibitor (PPI) use on the risk of hip fracture is... Lees meer
Gepost op 03 november 2019
-
The Joint Occurrence of Osteoporosis and Sarcopenia (Osteosarcopenia): Definitions and Characteristics.
J Am Med Dir Assoc. 2019 Oct 25;: Authors: Sepúlveda-Loyola W, Phu S, Bani Hassan E, Brennan-Olsen SL, Zanker J, Vogrin S, Conzade R, Kirk B, Al Saedi A, Probst V, Duque G OBJECTIVES: We sought to examine the... Lees meer
Gepost op 03 november 2019
-
Effect of Abaloparatide Versus Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis.
J Clin Endocrinol Metab. 2019 Nov 01;: Authors: Leder BZ, Mitlak B, Hu MY, Hattersley G, Bockman RS CONTEXT: The ACTIVE study demonstrated the antifracture efficacy of abaloparatide in postmenopausal women with... Lees meer
Gepost op 03 november 2019
-
Bone mineral density response with denosumab in combination with standard or high-dose teriparatide: the DATA-HD RCT.
J Clin Endocrinol Metab. 2019 Nov 01;: Authors: Ramchand SK, David NL, Leder BZ, Tsai JN CONTEXT: In the DATA-HD study, we reported that 15-months of combined high-dose (HD) teriparatide and denosumab increased mean areal... Lees meer
Gepost op 03 november 2019
-
Prescribing and adherence to bone protection medications following hip fracture in the United Kingdom: results from the World Hip Trauma Evaluation (WHiTE) cohort study.
Bone Joint J. 2019 11;101-B(11):1402-1407 Authors: Cehic M, Lerner RG, Achten J, Griffin XL, Prieto-Alhambra D, Costa ML AIMS: Bone health assessment and the prescription of medication for secondary fracture prevention... Lees meer
Gepost op 03 november 2019
-
Osteoporotic Fractures in Patients With Atrial Fibrillation Treated With Conventional Versus Direct Anticoagulants.
J Am Coll Cardiol. 2019 Oct 29;74(17):2150-2158 Authors: Binding C, Bjerring Olesen J, Abrahamsen B, Staerk L, Gislason G, Nissen Bonde A BACKGROUND: Elderly patients in long-term treatment with vitamin K antagonists... Lees meer
Gepost op 31 oktober 2019
-
Relationship between the FRAX index and physical and cognitive functioning in older people.
Ann Med. 2018 09;50(6):538-543 Authors: González Silva Y, Abad Manteca L, de la Red Gallego H, Álvarez Muñoz M, Rodríguez Carbajo M, Murcia Casado T, Ausín Pérez L, Abadía Otero... Lees meer
Gepost op 31 oktober 2019
-
The role of bone mineral density in therapeutic decision-making using the Fracture Risk Assessment Tool (FRAX): a sub-study of the Taiwan OsteoPorosis Survey (TOPS).
Arch Osteoporos. 2019 Oct 24;14(1):101 Authors: Chen JF, Yu SF, Hsu CY, Chiu WC, Wu CH, Lai HM, Chen YC, Su YJ, Chen JF, Cheng TT Fracture Risk Assessment Tool (FRAX)-based intervention threshold (IT) is widely applied... Lees meer
Gepost op 31 oktober 2019
-
Conventional antidiabetic agents and bone health: A pilot case-control study.
Perspect Clin Res. 2019 Oct-Dec;10(4):177-182 Authors: Raj JP, Venkatachalam S, Shekoba M, Norris JJ, Amaravati RS Background and Objectives: The burden of noncommunicable diseases such as diabetes (type 2 diabetes... Lees meer
Gepost op 31 oktober 2019
-
Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort study.
BMC Geriatr. 2019 Oct 28;19(1):290 Authors: Yu SF, Cheng JS, Chen YC, Chen JF, Hsu CY, Lai HM, Ko CH, Chiu WC, Su YJ, Cheng TT BACKGROUND: We investigated the association of anti-osteoporosis medication with mortality... Lees meer
Gepost op 31 oktober 2019
-
Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone.
Diabetes Care. 2019 Oct 28;: Authors: Koromani F, Oei L, Shevroja E, Trajanoska K, Schoufour J, Muka T, Franco OH, Ikram MA, Zillikens MC, Uitterlinden AG, Krestin GP, Anastassiades T, Josse R, Kaiser SM, Goltzman D, Lentle... Lees meer
Gepost op 31 oktober 2019
-
Effects of physical activity on bone mineral density in older adults: Korea National Health and Nutrition Examination Survey, 2008-2011.
Arch Osteoporos. 2019 Oct 26;14(1):103 Authors: Kim YA, Lee Y, Lee JH, Seo JH INTRODUCTION: Physical activity (PA) is widely recommended for osteoporosis. However, epidemiological data regarding the intensity or volume of... Lees meer
Gepost op 31 oktober 2019
-
Psychotropic Medications and Proton Pump Inhibitors and the Risk of Fractures in the Teriparatide versus Risedronate VERO Clinical Trial.
Bone. 2019 Oct 22;:115113 Authors: Kendler DL, Marin F, Geusens P, López-Romero P, Lespessailles E, Body JJ, Minisola S BACKGROUND: VERO is a fracture endpoint study in women with established osteoporosis that... Lees meer
Gepost op 31 oktober 2019
-
Bone Mineral Density After Transitioning From Denosumab to Alendronate.
J Clin Endocrinol Metab. 2019 Oct 26;: Authors: Kendler D, Chines A, Clark P, Ebeling PR, McClung M, Rhee Y, Huang S, Stad RK CONTEXT: There are few studies on subjects transitioning from denosumab to bisphosphonates.... Lees meer
Gepost op 31 oktober 2019
-
The effect of previous treatment with bisphosphonate and renal impairment on the response to denosumab in osteoporosis: a 'real-life' study.
J Endocrinol Invest. 2019 Oct 29;: Authors: Fraser TR, Flogaitis I, Moore AE, Hampson G PURPOSE: To investigate changes in bone mineral density (BMD) following denosumab after previous bisphosphonate therapy and the... Lees meer
Gepost op 31 oktober 2019
-
Effect of Weight Loss via Severe vs Moderate Energy Restriction on Lean Mass and Body Composition Among Postmenopausal Women With Obesity: The TEMPO Diet Randomized Clinical Trial.
JAMA Netw Open. 2019 Oct 02;2(10):e1913733 Authors: Seimon RV, Wild-Taylor AL, Keating SE, McClintock S, Harper C, Gibson AA, Johnson NA, Fernando HA, Markovic TP, Center JR, Franklin J, Liu PY, Grieve SM, Lagopoulos J,... Lees meer
Gepost op 31 oktober 2019
-
The role of sphingosine 1-phosphate metabolism in bone and joint pathologies and ectopic calcification.
Bone. 2019 Oct 21;:115087 Authors: El Jamal A, Bougault C, Mebarek S, Magne D, Cuvillier O, Brizuela Sphingolipids display important functions in various pathologies such as cancer, obesity, diabetes, cardiovascular or... Lees meer
Gepost op 27 oktober 2019